4.43 VKPrasad Lab Update Part 2 With Timothee Olivier


I am back with Timothee Olivier from Geneva Switzerland to discuss Part 2 of our laboratory work. Can oncologists criticize RCTs?


Previous
Previous

4.44 Cost Of Cancer Drugs - Basics In Cancer Drug Policy

Next
Next

4.42 Timothee Olivier, Geneva in the first Installment of VKPrasad Lab updates